MedTrace Logo

Study of Mobile Phone Support for the DC Tobacco Quitline

NCT01817842 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 803

Last updated 2013-03-26

No results posted yet for this study

Summary

This is a study of the effectiveness of mobile phone support for the D.C. Tobacco Quitline. The project will test the efficacy of a web-based system that uses mobile phones to improve quit rates at 3-month intervals, relative to standard quitline services. Under the standard model, relatively infrequent, periodic support is provided to smokers who want to quit and seek out the services. The new system will complement that effort by increasing the quality, frequency and accessibility of quit smoking support - when and where the smoker needs it most. It is hypothesized that successful abstinence rates will improve to the degree that participants utilize the support system and engage with the quitline.

Conditions

  • Smoking Cessation

Interventions

BEHAVIORAL

Mobile EX cessation support

Mobile EX cessation support is designed to enhance the Washington D.C. Quitline (DCQL) by giving participants the ability track their cessation attempt on a phone-based app and thus create a profile documenting their progress and set-backs over the days or weeks in between QL contacts. Participants receive summary information and graphics that help them understand what is working best for them. Participants also receive 24-hr, momentary access to a set of interactive cessation tools on their phone.

BEHAVIORAL

DC Quitline Support

Participants assigned to standard DC Quitline programming receive 6 proactive QL counseling sessions and optional, free nicotine replacement therapy (NRT).

BEHAVIORAL

Device Control

Mobile phone for use during cessation attempt but with no mEX support components

Sponsors & Collaborators

  • Truth Initiative

    lead OTHER

Principal Investigators

  • Thomas R Kirchner, PhD · Truth Initiative

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-07-31
Primary Completion
2012-02-29
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01817842 on ClinicalTrials.gov